Kaiser评分在乳腺磁共振成像评估乳腺癌中的诊断性能:系统评价与Meta分析
该系统评价与Meta分析纳入29项研究共7918例患者8451个乳腺病灶,评估Kaiser评分(KS)在MRI上检测和表征乳腺癌的性能。KS汇总敏感度95%、特异度70%、AUC 0.94,BI-RADS分别为97%、46%、0.89;敏感度差异无统计学意义(p=0.803),特异度差异有统计学意义(p=0.001)。KS对肿块型病灶诊断准确性略优于非肿块型病灶,且在较大病灶中表现更好。
要点
- KS汇总敏感度95%、特异度70%、AUC 0.94,特异度高于BI-RADS的46%(p=0.001)。
- KS对肿块型病灶AUC 0.96,略优于非肿块型病灶的AUC 0.91。
- KS在较大病灶中表现更好,其避免不必要活检的能力有助临床决策。
核心结论
- KS在MRI上检测乳腺恶性病灶的诊断性能优于BI-RADS,尤其特异度更高,其避免不必要活检的能力使其对诊断和临床决策有价值。
研究设计与样本
- 系统评价与Meta分析,方案预注册于https://osf.io/83c6j/,检索PubMed、Embase、Cochrane Library和Web of Science至2024年10月30日,纳入29项研究共7918例患者8451个乳腺病灶,采用QUADAS-2评估偏倚风险,采用随机效应双变量模型计算AUC、敏感度、特异度、阳性及阴性似然比和诊断比值比,当I²≥50%时用Meta回归探索异质性来源,P值<0.05为统计学显著。
诊断标准与关键数值
- KS检测MRI上乳腺恶性病灶的汇总敏感度95%(95%CI 94%~96%)、特异度70%(95%CI 64%~75%)、AUC 0.94(95%CI 0.91~0.96);BI-RADS分别为敏感度97%(95%CI 92%~99%)、特异度46%(95%CI 30%~62%)、AUC 0.89(95%CI 0.86~0.91);敏感度差异无统计学意义(p=0.803),特异度差异有统计学意义(p=0.001);肿块型病灶敏感度96%(95%CI 94%~97%)、特异度69%(95%CI 60%~77%)、AUC 0.96(95%CI 0.94~0.97),非肿块型病灶分别为93%(95%CI 88%~96%)、68%(95%CI 58%~77%)、AUC 0.91(95%CI 0.88~0.94)。
临床应用与阅片要点
- 作者认为KS诊断性能优于BI-RADS,尤其其避免不必要活检的能力使其对诊断和临床决策有价值;KS对肿块型病灶诊断准确性略优于非肿块型病灶,且在较大病灶中表现更好。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To assess the performance of Kaiser score (KS) in detecting and characterizing breast cancer on magnetic resonance imaging (MRI).
METHODS: The protocol was pre-registered at (https://osf.io/83c6j/). We performed a comprehensive search in PubMed, Embase, Cochrane Library, and Web of Science until 30 October 2024 for studies that used KS for detection of breast cancer on MRI. The risk of bias in the included studies was evaluated utilizing Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2). Diagnostic values of area under the curve (AUC), sensitivity, specificity, positive and negative likelihood ratios, and diagnostic odds ratio were calculated using a random-effects bivariate model. Meta-regression was used to explore the source of heterogeneity when I2 was ≥ 50 %. P-value < 0.05 was considered statistically significant.
RESULTS: A total of 29 studies with 7918 patients and 8451 breast lesions were included. The pooled sensitivity, specificity, and AUC of KS for detecting malignant breast lesions on MRI were 95 % (95 % CI = 94 % to 96 %), 70 % (95 % CI = 64 % to 75 %), and 0.94 (95 % CI = 0.91 to 0.96), while for Breast Imaging Reporting and Data System (BI-RADS), they were 97 % (95 % CI = 92 % to 99 %), 46 % (95 % CI = 30 % to 62 %), and 0.89 (95 % CI = 0.86 to 0.91). Sensitivity difference was not statistically significant (p-value = 0.803), but specificity difference was significant (p-value = 0.001). Also, KS demonstrated slightly better diagnostic accuracy for mass lesions with a sensitivity of 96 % (95 % CI = 94 % to 97 %), specificity of 69 % (95 % CI = 60 % to 77 %), and AUC of 0.96 (95 % CI = 0.94 to 0.97) compared to non-mass lesions with 93 % (95 % CI = 88 % to 96 %), 68 % (95 % CI = 58 % to 77 %), and 0.91 (95 % CI = 0.88 to 0.94) values, respectively. KS showed better performance in larger lesions.
CONCLUSION: The KS's superior diagnostic performance compared to BI-RADS, particularly its ability to avoid unnecessary biopsies, makes it valuable for diagnostic and clinical decision-making.
引用
- Mohammadzadeh S, Mohebbi A, Moradi Z, et al. Diagnostic performance of Kaiser score in the evaluation of breast cancer using MRI: A systematic review and meta-analysis. Eur J Radiol. 2025. PMID: 40121897. doi:10.1016/j.ejrad.2025.112055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。